17
Views
27
CrossRef citations to date
0
Altmetric
Original Article

Transplantation of CD34+ Hematopoietic Progenitor Cells

, , , , &
Pages 589-596 | Published online: 11 Jun 2009

References

  • Thomas E D, Storb R, Clift R A, et al. Bone marrow transplantation. N Engl J Med 1975; 292: 895–902
  • Appelbaum F R, Herzig G P, Ziegler J L, et al. Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma. Blood 1978; 52: 85–95
  • Armitage J O. Bone marrow transplantation. N Engl J Med 1994; 330: 827–838
  • Barrett J A. An introduction to bone marrow transplantation and processing. Bone Marrow Processing and Purging, A P Gee. CRC Press, Boca Raton, FL 1991; 3
  • Sheridan W P, Begley C G, Juttner C A, et al. Effect of peripheral-blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 1992; 79: 3036–3044
  • Peters W P, Rosner G, Ross M, et al. Comparative effects of granulocyte-macrophage colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use in autologous bone marrow after high-dose chemotherapy. Blood 1993; 81: 1709–1719
  • Noga S J. Graft engineering: The evolution of hematopoietic transplantation. J Hematother 1992; 1: 3–17
  • Antman K, Gale R P. Advanced breast cancer: High dose chemotherapy and bone marrow autotransplants. Ann Intern Med 1988; 108: 570–574
  • Antman K, Corringhan R, de Vries E, et al. Dose intensive therapy in breast cancer. Bone Marrow Transpl 1992; 10(Suppl 1)67–73
  • Smith D M, Weisenburger D D, Bierman P, et al. Acute renal failure associated with autologous bone marrow transplantation. Bone Marrow Transpl 1987; 2: 195–201
  • Styler M J, Topolsky D L, Crilley P A, et al. Transient high grade heart block following autologous bone marrow infusion. Bone Marrow Transpl 1992; 10: 435–438
  • Vriesendorp R, Aalders J G, Sleijfer T, et al. Effective high dose chemotherapy with autologous bone marrow infusion in resistant ovarian cancer. Gynecol Oncol 1984; 17: 271–276
  • Davis J M, Rowley S D, Braine H G, et al. Clinical toxicity of cryopreserved bone marrow graft infusion. Blood 1990; 75: 781–786
  • Stroncek D F, Fautsch S K, Lasky L C, et al. Adverse reactions in patients transfused with cryopreserved marrow. Transfusion 1991; 31: 521–526
  • Peters W P, Ross M, Vredenburgh J J, et al. Highdose chemotherapy and autologous bone marrow support as consolidation after standard dose adjuvant therapy for high risk primary breast cancer. J Clin Oncol 1993; 11: 1132–1143
  • Rapoport A P, Rowe J M, Packman C H, et al. Cardiac arrest after autologous marrow infusion. Bone Marrow Transpl 1991; 7: 401–403
  • O'Donnell J R, Burnett A K, Sheehan T, et al. Safety of dimethylsulfoxide. Lancet 1981; 1: 498
  • Kligman A. Topical pharmacology and toxicology of dimethylsulfoxide. Part 1. JAMA 1965; 193: 140–148
  • Hameroff S R, Otto C W, Kanel J, et al. Acute cardiovascular effects of dimethylsulfoxide. Ann NY Acad Sci 1983; 411: 94–99
  • Shlafer M, Matheny J L, Karow A M. Cardiac chronotropic mechanisms of dimethylsulfoxide: Inhibition of acetylcholinesterase and antagonism of negative chronotropy by atropine. Arch Int Pharmacodyn Ther 1976; 221: 21–31
  • Samoszuk M, Reid M, Toy P. Intravenous dimethylsulfoxide therapy causes severe hemolysis mimicking a hemolytic transfusion reaction. Transfusion 1983; 23: 405
  • Yellowlees P, Greenfield C, McIntyre N. Dimethylsulfoxide induced toxicity. Lancet 1980; 2: 1004–1006
  • Humblet Y, LeFebvre P, Jacques J L, et al. Concentration of bone marrow progenitor cells by separation on a Percoll gradient using the Haemonetics model 30. Bone Marrow Transpl 1988; 3: 63–67
  • Raljmakers R, de Witte T, Koekman E, et al. Enrichment of human bone marrow aspirates for low density mononuclear cells using a Haemonetics discontinuous blood cell separator. Vox Sang 1986; 50: 146–150
  • Fisch C, Feigenbaum H, Bowas J A. Non-paroxysmal A-V nodal tachycardia due to potassium. Am J Cardiol 1964; 14: 357–361
  • Pinski S L, Maloney J D. Adenosine: A new drug for acute termination of supraventricular tachycardia. Cleveland Clin J Med 1990; 57: 383–388
  • Janssen W E, Hiemenz J W, Fields K K, et al. Blood and bone marrow hematopoielic stem cells for transplantation: A comparative review. Cancer Control May, 1994; 225–230
  • Kessinger A, Schmit-Pokorny K, Smith D, et al. Cryopreservation and infusion of autologous peripheral blood stem cells. Bone Marrow Transpl 1990; 5: 25–27
  • Jones R J, Celano P, Sharkis S J, et al. Two phases of engraftment established by serial bone marrow transplantation in mice. Blood 1989; 73: 397–401
  • Jones R J, Wagner J E, Celano P, et al. Separation of pluripotent haematopoietic stem cells from spleen colony forming cells. Nature 1990; 347: 188–189
  • Brenner M K, Rill D R, Moen R C, et al. Gene-marking to trace origin of relapse after aulologous bone-marrow transplantation. Lancet 1993; 341: 85–86
  • Gribben J G, Saporito L, Barber M, et al. Bone marrows of non-Hodgkin's lymphoma patients with a bcl-2 translocation can be purged of polymerase chain reaction-detectable lymphoma cells monoclonal antibodies and imniunomagnetic bead depletion. Blood 1992; 80: 1083–1089
  • Moss T J, Sanders D G, Lasky L D, et al. Contamination of peripheral blood stem cell harvests by circulating neuroblastoma cells. Blood 1990; 76: 1879–1883
  • Ross A A, Cooper B W, Lazarus H M, et al. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using iminunocytochemical and clonogenic assay techniques. Blood 1993; 82: 2605–2610
  • Sharp J G, Kessinger A, Vaughan W P, et al. Detection and clinical significance of minimal tumor cell contamination of peripheral stem cell harvests. Int J Cell Cloning 1992; 10: 92
  • Berendsen H H, De Leij L, Postmus P E, et al. Detection of small cell lung cancer metastases in bone marrow aspirates using monoclonal antibody directed against neuroendocrine differentiation antigen. J Clin Pathol 1988; 41: 273–276
  • Cole R J, Rosen P P, Hakes T B, et al. Monoclonal antibodies detect occull breasl carcinoma metastases in the bone marrow of patients with early stage disease. Am J Surg Pathol 1988; 12: 333–340
  • Porro B, Menard S, Tagliabue E, et al. Monoclonal antibody detection of carcinoma cells in bone marrow biopsy specimens from breast cancer patients. Cancer 1988; 61: 2407–2411
  • Moss T J, Reynolds C P, Reisfeld R A, et al. Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma. N Engl J Med 1991; 324: 219–226
  • Brugger W, Bross K J, Glall M, et al. Mobilization of tumor cells and hematopoielic progenitor cells into peripheral blood of patients with solid tumors. Blood 1994; 83: 636–640
  • Gilmore M J, Prentice H G, Corringham R E, et al. A technique for the concentration of nucleated bone marrow cells for in vitro manipulation or Cryopreservation using the IBM 2991 blood cell processor. Vox Sang 1983; 45: 294–302
  • Areman E M, Sacher R A, Deeg H J. Processing and storage of human bone marrow: Survey of current practices in North America. Bone Marrow Transpl 1990; 6: 203–209
  • Civin C I, Strauss L C, Brovall D, et al. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG1a cells. J Immunol 1984; 133: 157–165
  • Tindle R W, Nichols R AB, Calovsky D, et al. A novel anti-myeloid monoclonal antibody BI-3C5 recognizes early myeloid and some lymphoid precursors and subclassifies human acute leukemias. Hybridoma 1984; 3: 106
  • Andrews R G, Singer J W, Bernstein I D. Monoclonal antibody 12–8 recognizes a 115-kd molecule present on both unipotent and mullipotent hematopoietic colony forming cells and their precursors. Blood 1986; 67: 842–845
  • Sutherland D R, Keating A. The CD34 antigen: Structure, biology and potential clinical applications. J Hematother 1992; 1: 115–129
  • Lu L, Walker D, Broxmeyer H E, et al. Characterization of adult human marrow hematopoielic progenitors highly enriched by two-color cell sorting with My10 and major histocompalibility class II monoclonal antibodies. J Immunol 1987; 139: 1823–1829
  • Strauss L C, Rowley S D, LaRussa V F, et al. Antigemc analysis of hematopoiesis. V. Characterization of My-10 antigen expression by normal lymphohematopoietic progenitor cells. Exp Hematol 1986; 14: 878–886
  • DiGiusto D, Chen S, Combs J, et al. Human fetal bone marrow early progenitors for T, B, and myeloid cells are found exclusively in the population expressing high levels of CD34. Blood 1994; 84: 421–432
  • Kessinger A, Armitage J O, Landmark J D, et al. Reconstitution of human hematopoielic function with autologous cryopreserved circulating stem cells. Exp Hematol 1986; 14: 192–196
  • Bell A J, Hamblin T J, Oscier D G. Circulating stem cell autografts. Bone Marrow Transpl 1986; 1: 103–110
  • Bender J G, Unverzagt K L, Walker D E, et al. Identification and comparison of CD34 positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood 1991; 77: 2591–2596
  • Duhrsen U, Villeval J L, Boyd J, et al. Effects of recombinant human granulocyte colony stimulating factor on hematopoietic progenitor cells in cancer patients. Blood 1988; 72: 2074–2081
  • Gianni A M, Siena S, Bregni M, et al. Granulocyte-macrophage colony stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet 1989; 2: 580–585
  • Siena S, Bregni M, Brando B, et al. Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high dose cyclophosphamide treated patienls: Enhancement by intravenous recombinant human granulocyte-macrophage colony stimulating factor. Blood 1989; 74, 1905–1914
  • To L B, Haylock D N, Thorp D, et al. The optimization of collection of peripheral blood stem cells for autotransplantation in acute myeloid leukaemia. Bone Marrow Transpl 1989; 4: 41–47
  • Berenson R J, Bensinger W I, Kalamasz D. Positive selection of viable cell populations using avidin-biotin immunoadsorption. J Immunol Meth 1986; 91: 11–19
  • Berenson R J, Bensinger W I, Kalamasz D, . Avidin-biotin immunoadsorption: A technique to purify cells and its potential applications. Progress in Bone Marrow Transplantation, R P Gale, R Champlin, et al. Alan R Liss, New York 1987; 423–428
  • Berenson R J, Andrews R G, Bensinger W I, et al. Antigen CD34+ marrow cells engraft lethally irradiated baboons. J Clin Invest 1988; 81: 951–955
  • Berenson R J, Bensinger W I, Hill R S, et al. Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma. Blood 1991; 77: 1717–1722
  • Berenson R J, Bensinger W I, Kalamasz D, . Transplantation of stem cells enriched by immunoadsorption. Advances in Bone Marrow Purging and Processing, D A Worthington-White, A P Gee, S Gross, et al. Wiley-Liss, New York 1992; 449–459
  • Berenson R J, Bensinger W I, Hill R, . Stem cell selection—Clinical experience. Marrow Purging and Processing, S Gross, A Gee, D A Worthmgton-White, et al. Wiley-Liss, New York 1990; 403–414
  • Shpall E J, Jones R B, Franklin W, et al. Transplantation of enriched CD34 positive autologous marrow into breast cancer patients following high dose chemotherapy: Influence of CD34+ peripheral blood progenitors and growth factors on engraftment. J Clin Oncol 1994; 12: 28–36
  • Shpall E J, Ball E D, Champlin R E, et al. A prospective randomized phase III study using the CEPRATE SC Stem Cell Concentrator to isolate CD34+ hematopoietic progenitors for autologous marrow transplantation after high dose chemotherapy. Blood 1993; 82(Suppl 1)83a
  • Anasetti C, Amos D, Beatty P G, et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med 1989; 320: 197–204
  • Beatty P G, Clift R A, Mickelson E M, et al. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 1985; 765–771
  • Anasetti C, Beatty P G, Storb R, et al. Effect of HLA incompatibility on graft versus host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma. Hum Immunol 1990; 29: 79–91
  • Beatty P G, Hansen J A, Longton G M, et al. Marrow transplantation from HLA-matched unrelated donors for treatment of hematdogic malignancies. Transplant 1988; 45: 714–718
  • Beatty P G, Anasetti C, Hansen J A, et al. Marrow transplantation from unrelated donors for treatment of hematologic malignancies: Effect of mismatching for one HLA locus. Blood 1993; 81: 249–253
  • Ash R C, Casper J T, Chitambar C R, et al. Successful allogeneic transplantation of T-cell depleted bone marrow from closely HLA-matched unrelated donors. N Engl J Med 1990; 322: 485–494
  • Kernan N A, Bartsch G, Ash R C, et al. Analysis of 462 unrelated marrow transplants facilitated by the National Marrow Donor Program. N Engl J Med 1993; 328: 593–602
  • Ash R C, Horowitz M M, Gale R P, et al. Bone marrow transplantation from related donors other than HLA-identical siblings: Effects of T cell depletion. Bone Marrow Transplant 1991; 7: 443–452
  • Andrews R G, Bryant E M, Bartelmez S H, et al. CD34+ marrow cells, devoid of T and B lymphocytes, reconstitute stable lymphopoiesis and myelopoiesis in lethally irradiated allogeneic baboons. Blood 1992; 80: 1693–1701
  • Noga S J, Cremo C A, Duff S C, et al. Large scale separation of human bone marrow by counterflow centrifugation elutriation. J Immunol Meth 1986; 92: 211–218
  • Noga S J, Donnenberg A D, Schwartz C L, et al. Development of a simplified counterflow centrifugation elutriation procedure for depletion of lymphocytes from human bone marrow. Transplant 1986; 41: 220–229

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.